Clinical trials
Hyperlipidemias trials with no applicable phase and unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
42 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2007 | 3 |
| 2008 | 2 |
| 2009 | 2 |
| 2010 | 1 |
| 2012 | 2 |
| 2013 | 3 |
| 2014 | 3 |
| 2016 | 2 |
| 2018 | 4 |
| 2019 | 3 |
| 2020 | 4 |
| 2021 | 1 |
| 2022 | 4 |
| 2023 | 6 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 42 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cairo University | 2 |
| Olive Lifesciences Pvt Ltd | 2 |
| University of Calgary | 2 |
| Asan Medical Center | 1 |
| Augusta University | 1 |
| Beijing Chao Yang Hospital | 1 |
| Brigham and Women's Hospital | 1 |
| China Medical University Hospital | 1 |
| Chung Shan Medical University | 1 |
| First Affiliated Hospital of Jinan University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hyperlipidemias | 42 |
| Hypertension | 15 |
| Cardiovascular Diseases | 7 |
| Obesity | 7 |
| Diabetes Mellitus, Type 2 | 6 |
| Hyperglycemia | 6 |
| Metabolic Syndrome | 5 |
| Inflammation | 4 |
| Dyslipidemias | 3 |
| Insulin Resistance | 3 |
Trials
Showing 1 to 25 of 42. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.